FIELD: medicine.
SUBSTANCE: method involves checking consciousness, blood coagulation state, peripheral blood leukocytes number, K+ ions, bilirubin, fibrinogen, hemolysis and hemoglobinuria availability, prothrombin index and exotoxic shock development. Each value is calculated in points as follows. Lucidity is evaluated as -2 points; depression - +3 points; coma - +6 points; lack of changes in blood coagulation system - -2 points; coagulation availability without clinical injuries - +2 points; coagulopathy with clinical manifestation signs - +19 points; K+ ions concentration being less than 3.0 mmole/l - +3 points, from 3.1 to 3.5 mmole/l - -5 points, from 3.6 to 5.0 mmole/l - 0 points, greater than 5.0 points - +7 points, failure in determining K+ ions concentration - 0 points; hemolysis availability - +6 points, its lack - -3 points; hemoglobinuria availability - +8 points, its lack - -1 points; leukocytes number being less than 12.0x109/l - -2 points, from 12,1 to 18.0x109/l - 0 points, higher than 18.0x109/l - +8 points; hourly urine output being less than 30 ml/h - +6 points, greater than 30 ml/h - -2 points; bilirubin content being less than 31 mcmole/l - -2 points, from 30.1 to 50.0 mcmole/l - 0 points, greater than 50.0 mcmole/l - +2 points, failure in determining bilirubin content due to hemolysis being available -+6 points; prothrombin index being equal to or less than 60% - +3 points, greater than 60% - 0 points, failure in determining prothrombin index due to hemolysis being available - +12 points; fibrinogen concentration in blood plasma being less than 2.1 g/l - +4 points, from 2.1 to 4.0 g/l - -1 point, from 4.1 to 6.0 g/l - +1 point, failure in determining fibrinogen concentration due to erythrocyte hemolysis being available - +13 points; exotoxic shock development - +9 points, its lack - -1 point. The points are summed up. The value being greater than +13, admission for treatment in resuscitation department is indicated. The value being less than -13, admission for treatment in therapeutics department is indicated. The value being from -13 to +13, resuscitation expert consultation is advised.
EFFECT: high evaluation accuracy.
3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING THE RESULT OF ACUTE PERORAL INTOXICATION WITH CAUTERIZING LIQUIDS | 2003 |
|
RU2244930C2 |
METHOD FOR ADMINISTERING MEDICAL CARE TO PATIENTS AT PRE-ADMISSION STAGE IN ACUTE POISONING WITH ACETIC ACID | 2005 |
|
RU2278609C1 |
METHOD FOR EVALUATING THE NEED IN RESUSCITATION AID IN PATIENTS WITH ACUTE INTOXICATIONS WITH CARBON MONOXIDE | 2003 |
|
RU2245669C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF HEMOSTASIS SYSTEM DISORDERS IN PATIENTS WITH ACUTE BLOOD LOSS | 2004 |
|
RU2263914C1 |
METHOD FOR PREDICTION OF DEVELOPMENT OF EXOTOXIC SHOCK IN ACUTE TOXIC EXPOSURE TO ACETIC ACID | 2008 |
|
RU2385459C2 |
METHOD FOR PREDICTING IN ACUTE BLOOD LOSS PATIENTS | 2004 |
|
RU2269129C1 |
METHOD FOR CHOOSING DETOXICATION APPROACH TO ACUTE SURGICAL ABDOMINAL PATHOLOGY | 2011 |
|
RU2447441C1 |
METHOD OF HEMODIALYSIS AT PATIENTS WITH RISK OF BLEEDING | 2004 |
|
RU2343936C2 |
METHOD FOR PREDICTING SEVERITY PATTERN OF HEMORRHAGIC SHOCK AFTER ACUTE MASSIVE HEMORRHAGE | 2002 |
|
RU2224456C1 |
METHOD FOR PREDICTING ACUTE PULMONARY LESION SYNDROME DEVELOPMENT CHANCES IN ACUTE HEMORRHAGE PATIENTS | 2004 |
|
RU2273852C2 |
Authors
Dates
2005-04-27—Published
2003-09-08—Filed